A detailed history of State Street Corp transactions in Axogen, Inc. stock. As of the latest transaction made, State Street Corp holds 799,051 shares of AXGN stock, worth $5.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
799,051
Previous 792,087 0.88%
Holding current value
$5.79 Million
Previous $5.41 Million 19.21%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.63 - $10.69 $46,171 - $74,445
6,964 Added 0.88%
799,051 $6.45 Million
Q4 2023

Feb 14, 2024

BUY
$3.61 - $7.76 $107,393 - $230,852
29,749 Added 3.9%
792,087 $5.41 Million
Q3 2023

Nov 14, 2023

SELL
$4.68 - $9.26 $745,917 - $1.48 Million
-159,384 Reduced 17.29%
762,338 $3.81 Million
Q2 2023

Aug 14, 2023

SELL
$8.5 - $10.38 $505,937 - $617,838
-59,522 Reduced 6.07%
921,722 $8.42 Million
Q1 2023

May 15, 2023

BUY
$7.53 - $10.95 $852,478 - $1.24 Million
113,211 Added 13.04%
981,244 $9.27 Million
Q4 2022

Feb 14, 2023

BUY
$9.44 - $13.09 $311,435 - $431,852
32,991 Added 3.95%
868,033 $8.66 Million
Q3 2022

Nov 15, 2022

SELL
$8.14 - $12.25 $696,026 - $1.05 Million
-85,507 Reduced 9.29%
835,042 $9.95 Million
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $1.11 Million - $1.59 Million
-158,757 Reduced 14.71%
920,549 $7.54 Million
Q1 2022

May 16, 2022

BUY
$7.26 - $10.7 $225,553 - $332,427
31,068 Added 2.96%
1,079,306 $8.57 Million
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $670,674 - $1.22 Million
76,213 Added 7.84%
1,048,238 $9.82 Million
Q3 2021

Nov 15, 2021

SELL
$15.23 - $21.72 $451,676 - $644,150
-29,657 Reduced 2.96%
972,025 $15.4 Million
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $324,796 - $428,804
18,247 Added 1.86%
1,001,682 $21.6 Million
Q1 2021

May 17, 2021

BUY
$17.18 - $22.6 $1.36 Million - $1.78 Million
78,904 Added 8.72%
983,435 $19.9 Million
Q4 2020

Feb 16, 2021

SELL
$11.5 - $17.96 $1.23 Million - $1.91 Million
-106,532 Reduced 10.54%
904,531 $16.2 Million
Q3 2020

Nov 10, 2020

SELL
$10.62 - $13.12 $1.84 Million - $2.28 Million
-173,467 Reduced 14.64%
1,011,063 $11.8 Million
Q2 2020

Aug 14, 2020

BUY
$7.35 - $10.81 $1.71 Million - $2.52 Million
232,835 Added 24.47%
1,184,530 $10.9 Million
Q1 2020

May 11, 2020

BUY
$8.38 - $17.34 $7.98 Million - $16.5 Million
951,695 New
951,695 $9.9 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $306M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.